In short, the GLP-1 agonist market is already worth >$35bn per annum, with only 4 drugs on the market, derived from only two underlying molecular entities. If Structure's drug candidates make it ...

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

In this comprehensive guide, we will explore the PharmaZee GLP-1 program, including how it works, the pricing structure, the benefits, and common FAQs. GLP-1, or glucagon-like peptide-1 ...

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial ...

Since GLP-1 agonists soared in popularity thanks to their powerful ... Science History Institute invites monthly speakers who are leaders from a wide variety of chemical and life science companies to ...

Ray Stevens, Structure Therapeutics CEO, joins 'Fast Money' to talk advancements in weight loss drugs and the development of a GLP-1 pill. GOP senators line up with Democrats to oppose Canada ...

Flavonoids are categorized into several subclasses based on their chemical structure ... including glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), peptide ...

At the most recent meeting of the American Chemical Association, a research team presented their findings that could solve the GLP-1 shortage. They suggest that an improvement in GLP-1 drug delivery, ...

SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics ... present his team’s results at the spring meeting of the American Chemical Society (ACS) ...